Quick Takeaways
- Timothy A. Springer filed SCHEDULE 13D/A for Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC).
- Disclosed ownership: 37%.
- Date of event: 13 Jan 2025.
Timothy A. Springer - 13 Jan 2025 SCHEDULE 13D/A Report for Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC)
- Filing Manager
- Timothy A. Springer
- Reporting Manager
- Timothy A. Springer
- Symbol
- RNAC
- Shares outstanding
- 25,895,377 shares
- Disclosed Ownership
- 9,555,394 shares
- Ownership
- 37%
- Form type
- SCHEDULE 13D/A
- Filing time
- 15 Jan 2025, 16:25:12 UTC
- Date of event
- 13 Jan 2025
- Previous filing
- 23 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Timothy A. Springer disclosed 37% ownership in Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC) on 13 Jan 2025."
What Changed
- Previous schedule filing date: 23 Dec 2024.
- Current filing was accepted on 15 Jan 2025, 16:25.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Timothy A. Springer | 37% | 9,555,394 | 9,555,394 | 0 | /s/ Timothy A. Springer | Timothy A. Springer | 0001055624 |
| TAS Partners LLC | 2.2% | 563,206 | 563,206 | 0 | /s/ Timothy A. Springer | Timothy A. Springer/Manager | 0001677543 |
| Chafen Lu | 1.4% | 350,740 | 350,740 | 0 | /s/ Chafen Lu | Chafen Lu |